The U.S. Food and Drug Administration (FDA) approved six new therapies in December 2025 for blood cancers, prostate cancer, ...

Breast cancer survivors with dense breast tissue should be proactive in their screening approach, considering both 3D ...

Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted ...

George: The phase 1/2 study is evaluating a new compound called DCC-3009. It is a drug that was designed specifically to work ...

Life changes post-diagnosis included early retirement due to immune compromise and personal milestones like adopting a new ...

The Hepzato Kit is the first FDA-approved liver-directed therapy for unresectable metastatic uveal melanoma, showing ...

HPV is a significant risk factor for anal cancer, with 90% of cases linked to the virus. Awareness of symptoms is crucial for early detection. Support systems, including family and community ...

Susie Sanchez is an anal cancer thriver, advocate for HPV awareness, and passionate about helping others speak openly about cancer risks. I share how an overlooked symptom led to my anal cancer ...

The EVEREST-2 study reported the first complete response to CAR-T cell therapy in a non-small cell lung cancer patient.

A PSA of 127 indicated a high probability of prostate cancer, leading to immediate Lupron ADT therapy and radiation treatment ...

Rusfertide effectively maintained hematocrit control below 45% and reduced phlebotomy eligibility in PV patients through 52 ...

Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with ...